Landscapes / Companies
Biokin (Shanghai) Biopharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 1 checked
Trials
4 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2029Phase 3 trial completes | |||
| Next date | Dec 2029 · Phase 3 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Gastric Adenocarcinoma and 6 more | ||||
| Open drug page | |||||
BL-M14D1not checked |
— |
Sichuan Baili (Biokin, SystImmune) |
Phase 2 | Dec 2027Phase 2 trial completes | |
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Small Cell Lung Cancer, Neuroendocrine Tumors and 1 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021